Table 2

The percentage of samples from 84 participants (95% CI; N) containing at least one faecal E coli isolate resistant to the tested antimicrobials; overall and stratified by hospital

ResistanceAll participantsFAHEHSAH
AMP53.6 (42.9 to 64.2; 45)56.3 (39.1 to 73.4; 18)55.0 (33.2 to 76.8; 11)50.0 (32.7 to 67.3; 16)
AMC10.7 (4.10 to 17.3; 9)15.6 (3.04 to 28.2; 5)5.0 (0 to 14.6; 1)9.38 (0 to 19.5; 3)
NAL25.0 (15.7 to 34.3; 21)28.1 (12.5 to 43.7; 9)25.0 (6.02 to 44.0; 5)21.9 (7.55 to 36.2; 7)
CIP11.9 (4.98 to 18.8; 10)15.6 (3.04 to 28.2; 5)10.0 (0 to 23.1; 2)9.38 (0 to 19.5; 3)
CHL16.7 (8.70 to 24.6; 14)15.6 (3.04 to 28.2; 5)20.0 (2.47 to 37.5; 4)15.6 (3.04 to 28.2; 5)
TMP34.5 (24.4 to 44.7; 29)50.0 (32.7 to 67.3; 16)40.0 (18.5 to 61.5; 8)15.6 (3.04 to 28.2; 5)
TET39.3 (28.8 to 49.7; 33)46.9 (29.6 to 64.2; 15)40.0 (18.5 to 61.5; 8)31.3 (15.2 to 47.3; 10)
BLM53.6 (42.9 to 64.2; 45)56.3 (39.1 to 73.4, 18)55.0 (33.2 to 76.8; 11)50 (32.7 to 67.3; 16)
QNL25.0 (15.7 to 34.3; 21)28.1 (12.5 to 43.7; 9)25.0 (6.02 to 44.0; 5)21.9 (7.55 to 36.2; 7)
3GCR10.7 (4.10 to 17.3; 9)9.38 (0 to 19.5; 3)5.0 (0 to 14.6; 1)15.6 (3.04 to 28.2; 5)
AMR60.7 (50.3 to 71.2, 51)59.4 (42.4 to 76.4; 19)65.0 (44.1 to 85.9; 13)59.4 (42.4 to 76.4; 19)
MDR32.1 (22.2 to 42.1; 27)40.6 (23.6 to 57.6, 13)35.0 (14.1 to 55.9; 7)21.9 (7.55 to 36.2; 7)
ALL7.14 (1.64 to 12.7; 6)12.5 (1.04 to 24.0; 4)5.0 (0 to 14.6; 1)3.13 (0 to 9.15; 1)
ESBL5.95 (0.892 to 11.0; 5)3.13 (0 to 9.15; 1)5.0 (0 to 14.6; 1)9.38 (0 to 19.5; 3)
  • ALL, resistance to all five tested antimicrobial classes (β-lactams, quinolones, chloramphenicol, trimethoprim and tetracycline); AMC, amoxicillin clavulanate resistance; AMP, ampicillin resistance; AMR, resistance to≥1 tested antimicrobial; BLM, β-lactam resistance; CHL, chloramphenicol resistance; CIP, ciprofloxacin resistance; EH, equine hospital; ESBL, sample contained ESBL-producing E coli.; FAH, farm animal hospital; MDR, resistance to≥3 tested antimicrobials; NAL, nalidixic acid resistance; QNL, quinolone resistance; SAH, small animal hospital; TET, tetracycline resistance; TMP, trimethoprim resistance; 3GCR, third-generation cephalosporin resistance